AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
Active, not recruiting · NCT05182905 · Registry updated 2026-03-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Early phase 1 | 2026-03-09 | NCT05182905 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Barrow Neurological Institute | 11 |
| Ivy Brain Tumor Center | 6 |
| Nader Sanai | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | United States | 30 |